p53 promotes the fidelity of DNA end-joining activity by, in part, enhancing the expression of heterogeneous nuclear ribonucleoprotein G

DNA Repair

Volumn 6, Issue 6, 2007, Pages 830-840

  Shin, Ki Hyuk ^a,b   Kim, Reuben H ^a   Kang, Mo K ^a,b   Kim, Roy H ^a   Kim, Steve G ^a   Lim, Philip K ^a   Yochim, Ji Min ^a   Baluda, Marcel A ^a,b   Park, No Hee ^a,b  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNA end joining; DSBs repair; hnRNP G; p53

Indexed keywords

DOUBLE STRANDED DNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN G; NUCLEASE; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; WILD TYPE;

CELL LINE, TUMOR; CLONING, MOLECULAR; DNA; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENETIC VECTORS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; KERATINOCYTES; RETROVIRIDAE; RNA, SMALL INTERFERING; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34247571926     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2007.01.013     Document Type: Article

References (30)

1. Pierce A.J., Stark J.M., Araujo F.D., Moynahan M.E., Berwick M., and Jasin M. Double-strand breaks and tumorigenesis. Trends Cell Biol. 11 (2001) S52-S59
2. Kabotyanski E.B., Gomelsky L., Han J., Stamato T.D., and Roth D.B. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucl. Acids Res. 6 (1998) 5333-5342
3. Liang F., and Jasin M. Ku80-deficient cells exhibit excess degradation of extra chromosomal DNA. J. Biol. Chem. 271 (1996) 14405-14411
4. Roth D.B. Restraining the V(D)J recombinase. Nat. Rev. Immunol. 3 (2003) 656-666
5. Bentley J., Diggle C.P., Harnden P., Knowles M.A., and Kiltie A.E. DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. Nucl. Acids Res. 32 (2004) 5249-5259
6. Shin K.-H., Ahn J.H., Kang M.K., Lim P.K., Yip F.K., Baluda M.A., and Park N.-H. HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways. Int. J. Oncol. 28 (2006) 209-215
7. Shin K.-H., Kang M.K., Kim R.H., Kameta A., Baluda M.A., and Park N.-H. Abnormal DNA end-joining activity in human head and neck cancer. Int. J. Mol. Med. 17 (2006) 917-924
8. Liu Y., and Kulesz-Martin M. p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis 22 (2001) 851-860
9. Bakalkin G., Selivanova G., Yakovleva T., Kiseleva E., Kashuba E., Magnusson K., Szekely L., Klein G., Terenius L., and Wiman K. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucl. Acids Res. 23 (1995) 362-369
10. Lee S., Elenbaas B., Levine A., and Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA-damage in the form of insertion/deletion mismatches. Cell 81 (1995) 1013-1020
11. Oberosler P., Hloch P., Ramsperger U., and Stahl H. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12 (1993) 2389-2396
12. Lilling G., Elena N., Sidi Y., and Bakhanashvili M. p53-associated 3′ → 5′ exonuclease activity in nuclear and cytoplasmic compartments of cells. Oncogene 22 (2003) 233-245
13. Mummenbrauer T., Janus F., Muller B., Wiesmuller L., Deppert W., and Grosse F. p53 protein Exhibits 3′-to-5′ exonuclease activity. Cell 85 (1996) 1089-1099
14. Nelson W.G., and Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14 (1994) 1815-1823
15. Lin Y., Waldman B.C., and Waldman A.S. Suppression of high-fidelity double-strand break repair in mammalian chromosomes by pifithrin-alpha, a chemical inhibitor of p53. DNA Repair 2 (2003) 1-11
16. Delbridge M.L., Lingenfelter P.A., Disteche C.M., and Graves J.A. The candidate spermatogenesis gene RBMY has a homologue on the human × chromosome. Nat. Genet. 22 (1993) 223-224
17. Soulard M., Della Valle V., Siomi M.C., Pinol-Roma S., Codogno P., Bauvy C., Bellini M., Lacroix J.C., Monod G., Dreyfuss G., and Larsen C.-J. HnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucl. Acids Res. 21 (1993) 4210-4217
18. Dreyfuss G., Matunis M.J., Piuol-Roma S., and Burd C.G. hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62 (1993) 289-321
19. Soulard M., Barque J.P., Della Valle V., Hernandez-Verdun D., Masson C., Danon F., and Larsen C.J. A novel 43-kDa glycoprotein is detected in the nucleus of mammalian cells by autoantibodies from dogs with autoimmune disorders. Exp. Cell Res. 193 (1991) 59-71
20. Nasim M.T., Chernova T.K., Chowdhury H.M., Yue B.G., and Eperon I.C. HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding. Hum. Mol. Genet. 12 (2003) 1337-1348
21. Shin K.-H., Kang M.K., Kim R.H., Christensen R., and Park N.-H. Heterogeneous nuclear ribonucleoprotein G (hnRNP G) demonstrates tumor suppressive activity against oral squamous cell carcinoma cells. Clin. Cancer Res. 12 (2006) 3222-3228
22. Shin K.-H., Min B.-M., Cherrick H.M., and Park N.-H. Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol. Carcinog. 9 (1994) 76-86
23. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
24. Alkan S.A., Martincic K., and Milcarek C. The hnRNPs F and H2 bind to similar sequences to influence gene expression. Biochem. J. 393 (2006) 361-371
25. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Zhang M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
26. Kang M.K., Shin K.-H., Yip F.K., and Park N.-H. Normal human oral keratinocytes demonstrate abnormal DNA end joining activity during replicative senescence. Mech. Ageing Dev. 126 (2005) 475-479
27. Shin K.-H., Kang M.K., Dicterow E., Kameta A., Baluda M.A., and Park N.-H. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin. Cancer Res. 10 (2004) 2551-2560
28. Krecic A.M., and Swanson M.S. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell. Biol. 11 (1999) 363-371
29. Li B., and Lee M.Y. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J. Biol. Chem. 276 (2001) 29729-29739
30. Brosh Jr. R.M., Karmakar P., Sommers J.A., Yang Q., Wang X.W., Spillare E.A., Harris C.C., and Bohr V.A. p53 Modulates the exonuclease activity of Werner syndrome protein. J. Biol. Chem. 276 (2001) 35093-35102